(Q36080891)

12 August 2017

Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency (English)

1 reference

12 August 2017

0 references

0 references

Tsutsumi Y

1

1 reference

12 August 2017

Kihira T

2

1 reference

12 August 2017

Tsunoda S

3

1 reference

12 August 2017

Kanamori T

4

1 reference

12 August 2017

Nakagawa S

5

1 reference

12 August 2017

Mayumi T

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

5

1 reference

12 August 2017

963-968

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.186

12 August 2017

0 references

cites work

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Phase I study of recombinant human tumor necrosis factor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

The role of interferons in the treatment of solid tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

An endotoxin-induced serum factor that causes necrosis of tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Renal filtration, transport, and metabolism of low-molecular-weight proteins: A review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

A pharmacokinetic analysis program (multi) for microcomputer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Phase I study of recombinant tumor necrosis factor in cancer patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033790

Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity

11 July 2018

1 reference

12 December 2020

Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol

1 reference

12 December 2020

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

12 December 2020

Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates

1 reference

12 December 2020

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

1 reference

12 December 2020

Human tumor necrosis factor. Production, purification, and characterization

1 reference

12 December 2020

Preparation and characterization of recombinant DNA-derived human interferon-gamma

1 reference

12 December 2020

Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity

1 reference

12 December 2020

Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor

1 reference

12 December 2020

Phase I study of intratumoral application of recombinant human tumor necrosis factor

1 reference

12 December 2020

Evaluation of recombinant human tumor necrosis factor by scheduled intratumoral administration in mice bearing transplantable tumors

1 reference

12 December 2020

Site-directed pegylation of recombinant interleukin-2 at its glycosylation site

1 reference

12 December 2020

Characterization of a polyethylene glycol conjugate of recombinant human interferon-gamma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.186

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

7734321

1 reference